The Valley Desk

NCT06834360 · Interventional trial

A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps

Overall registry status Active not recruiting

Phase 3

Conditions Chronic Rhinosinusitis With Nasal Polyps

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov